STREAMING NOW: Watch Now

US launches advanced trials of antibody treatment for Covid-19 patients

Two new trials soon will be underway in the United States to investigate antibody treatment approaches for Covid-19 patients.The...

Posted: Aug 4, 2020 1:21 PM

Two new trials soon will be underway in the United States to investigate antibody treatment approaches for Covid-19 patients.

The National Institutes of Health announced on Tuesday that it is launching two advanced trials to test monoclonal antibodies in patients with Covid-19, one for patients with mild disease and another for patients who are hospitalized.

Monoclonal antibodies are immune system proteins that specifically home in on a single target. In coronavirus, they are targeted to a single structure on the body of the virus. The hope is to slow or even prevent infection.

"Studying the impact of this investigational therapeutic on multiple patient populations at the same time is critical to determining whether it can help Covid-19 patients with differing levels of disease severity," Dr. Anthony Fauci, the nation's top infectious disease expert and director of the National Institute of Allergy and Infectious Diseases Director, said in the announcement.

"These concurrent trials have the potential to yield significant and comprehensive clinical data," he said.

NIH starts antibody treatment clinical trials

In April, NIH announced the formation of the program Accelerating COVID-19 Therapeutic Interventions in Vaccine or ACTIV.

Since then, the program has "evaluated hundreds" of therapeutic agents with potential application to Covid-19, NIH Director Dr. Francis Collins said on Tuesday. The two newly launched advanced trials are part of that ACTIV program.

"Today we are announcing the first therapeutic trial to be launched as part of ACTIV. ACTIV 2 is a Phase 2 trial of the Eli Lilly monoclonal antibody that can expand seamlessly to Phase 3," Collins said during a phone call with reporters on Tuesday.

That Phase 2 trial will include people with mild disease who are not hospitalized for coronavirus treatment, Collins said.

Fauci added that the "fundamental strategy" for a monoclonal antibody "is to interfere with the virus's ability to infect," and the goal of the trial is to see if the treatment approach "reduces the duration of symptoms."

The ACTIV 2 Phase 2 trial will be done in eight weeks and researchers should know by October or November if the therapeutic works, Fauci said.

ACTIV also will include a more advanced, Phase 3 trial, Collins said.

"ACTIV 3 is a Phase 3 trial in hospitalized adults, but also begins with Lilly's monoclonal, but allows for other types of therapeutics as well," he said.

Specifically, ACTIV 3 will be for patients who require hospitalization but without end stage organ failure, Fauci said. "The primary objective is a sustained recovery for 14 days at home, after hospital discharge," he said.

Collins said that NIH is "thrilled" about launching the two trials.

"So keeping them straight: ACTIV 2 -- outpatient, ACTIV 3 -- inpatients," he said. "We're thrilled to reach this point in record time."

The monoclonal antibody treatment being studied in the two trials is named LY-CoV555. It was made by the pharmaceutical company Eli Lilly and Co. in cooperation with AbCellera from an antibody first identified in a blood sample taken from one of the first US patients to recover from Covid-19.

The NIH trial of Eli Lilly's antibody treatment is just one of many.

'We don't have that time'

In June, Lilly became the first company in the United States to start testing an antibody therapy in humans and now it has several antibody therapy trials that are ongoing.

"The creation, testing and approval of a novel custom designed monoclonal antibody medicine like this usually takes years, if not a decade. We don't have that time," Lilly chief scientific officer Dr. Dan Skovronsky said.

One trial underway is a Phase 3 trial that is currently recruiting residents and staff in long-term care facilities that have a recent case of Covid-19. That trial launched Monday.

US trials that Lilly launched in June have been looking at the impact its antibody treatment LY-CoV555 had in hospitalized patients and in people with mild to moderate symptoms.

Eli Lilly also has a separate trial in China of another antibody treatment it developed with Junshi Biosciences, called JS016. The company said in the future it plans to test other antibodies, and what's known as a cocktail form of antibody treatment, that have shown to neutralize the virus well in the lab.

Overall, there are at least 60 monoclonal antibody therapies and 12 convalescent plasma treatments for Covid-19 under investigation as of August, according to Bio, an association that represents the biopharma industry.

Once proven to be safe and effective, how much a monoclonal antibody therapy could cost and how many doses the US government might buy remains to be seen.

While the federal government may be buying up possible coronavirus vaccines ahead of time, buying treatments such as drugs and antibodies is a different matter, Dr. Janet Woodcock, a Food and Drug Administration official who leads therapeutics development for Operation Warp Speed, said during a phone call with reporters on Tuesday.

"The therapeutic landscape is much wider," Woodcock said, adding there are multiple different modalities of therapy.

She said that advanced purchasing of therapeutics is going to be slower, because, "out of these vast inventories of potential candidates, we have to select the most promising ones. We can't just buy advanced purchases of 600 different agents."

With vaccines "it's very clear what you're going to do," she said. "The primary goal is to vaccinate people and protect them... with therapeutics it's a little more complicated."

Oregon Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 31865

Reported Deaths: 539
CountyConfirmedDeaths
Multnomah7022136
Marion456992
Washington441759
Umatilla293941
Clackamas234661
Malheur158926
Jackson11094
Lane109616
Deschutes79312
Yamhill75013
Jefferson5218
Polk51515
Linn49513
Morrow4946
Lincoln47613
Union4392
Benton2946
Klamath2792
Wasco2793
Hood River2490
Douglas2244
Josephine1952
Columbia1551
Coos1490
Clatsop1310
Baker922
Crook621
Tillamook510
Curry310
Lake290
Wallowa281
Sherman180
Harney120
Grant90
Gilliam80
Unassigned00
Wheeler00

California Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 799516

Reported Deaths: 15393
CountyConfirmedDeaths
Los Angeles2644146455
Riverside578831179
San Bernardino53359918
Orange526221182
San Diego45596773
Kern31712360
Fresno28019362
Sacramento21872399
Alameda20951397
Santa Clara20756304
San Joaquin20126437
Stanislaus16436345
Contra Costa16238204
Tulare15829259
Ventura12591146
Imperial11741317
San Francisco1094699
San Mateo9714144
Monterey970170
Santa Barbara8973113
Merced8828140
Kings756977
Sonoma7262120
Marin6641114
Solano627863
Madera445865
Placer353544
San Luis Obispo347929
Butte279043
Yolo278255
Santa Cruz22949
Sutter168911
Napa165313
San Benito132111
Yuba11367
El Dorado10884
Mendocino89418
Shasta75916
Lassen7360
Glenn5713
Tehama5334
Lake53011
Nevada5286
Colusa5246
Humboldt4967
Calaveras31414
Amador29616
Tuolumne2274
Inyo18715
Mono1652
Siskiyou1630
Del Norte1381
Mariposa752
Plumas500
Modoc250
Trinity150
Sierra60
Alpine20
Unassigned00
Medford
Clear
50° wxIcon
Hi: 69° Lo: 56°
Feels Like: 50°
Brookings
Few Clouds
57° wxIcon
Hi: 61° Lo: 57°
Feels Like: 57°
Crater Lake
Clear
38° wxIcon
Hi: 63° Lo: 49°
Feels Like: 38°
Grants Pass
Overcast
45° wxIcon
Hi: 71° Lo: 56°
Feels Like: 37°
Klamath Falls
Clear
38° wxIcon
Hi: 69° Lo: 47°
Feels Like: 38°
Spotty afternoon showers
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events

Latest Video

Image

Friday, September 25 morning weather

Image

Happy Camp Hero

Image

New multi-agency resource center opened in Medford

Image

Thursday, September 24th Evening Weather

Image

Community of Happy Camp begins recovery after Slater Fire destruction

Image

Thursday, September 24 afternoon weather

Image

Thursday, September 24 morning weather

Image

LCC K9 MINISTRY SENDS COMFORT DOGS TO JACKSON COUNTY

Image

Wednesday, September 23rd Evening Weather

Image

Wednesday, September 23 afternoon weather